The HIV protease inhibitor ritonavir blocks osteoclastogenesis and function by impairing RANKL-induced signaling

Michael W.-H. Wang, F. Patrick Ross(Washington University in St. Louis)
Journal of Clinical Investigation
July 15, 2004
Cited by 13


Related Papers